Clinical trial
A PAncreatic Cancer Screening Study in Individuals With New-Onset or DeteriOrating Diabetes MEllitus (PANDOME Study)
NCT03937453 is registered in ClinicalTrials.gov with Nuvance Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A PAncreatic Cancer Screening Study in Individuals With New-Onset or DeteriOrating Diabetes MEllitus (PANDOME Study)
- Lead sponsor
- Nuvance Health
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 19, 2018
- Completion date
- January 19, 2028
- Enrollment
- 800 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, pancreatic cancer, pancreatic neoplasms